MedTrace Logo

Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19

NCT04586114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-10-19

No results posted yet for this study

Summary

Study conducted on hospitalized patient in critical ill units in Nancy and Metz to evaluate if early corticosteroid treatment in first seven days after admission improve patients outcome in Acute Respiratory Distress Syndrome secondary to Covid-19 compared to later corticosteroid therapy or no treatment. Also comparison of acquired infection with or without corticosteroid treatment during hospitalisation.

Conditions

  • Acute Respiratory Distress Syndrome Secondary to Covid-19

Interventions

DRUG

Corticosteroids and Derivatives

Any systemic corticosteroid treatment administrated during ICU stay

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Sebastien GIBOT · Central Hospital, Nancy, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-05-31
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04586114 on ClinicalTrials.gov